Pradžia › Vėžys (visų tipų) › Texas › Austin
Vėžys (visų tipų) klinikiniai tyrimai Austin, TX
20 tyrimai dėl Vėžys (visų tipų) ieško dalyvių vietose Austin ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.
Oficialus tyrimo tekstas (anglų kalba)
Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Renkami dalyviai2 fazė
- Texas Oncology-Austin North /ID# 279958, Austin
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
Renkami dalyviai3 fazė
- Texas Oncology, Austin
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
Renkami dalyviai1 fazė
- NEXT Oncology, Austin
Prospective Study to Assess a Diagnostic Aid for Cancer
Renkami dalyviaiStebimasis tyrimas
- Premier Family Physicians, Austin
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Renkami dalyviai2 fazė
- Dell Medical School, University of Texas at Austin, Austin
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
Renkami dalyviai1/2 fazė
- NEXT Oncology ( Site 1010), Austin
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Renkami dalyviai1 fazė
- NEXT Oncology - Austin, Austin
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Renkami dalyviai3 fazė
- USO - Texas Oncology, Austin
Project: Every Child for Younger Patients With Cancer
Renkami dalyviaiStebimasis tyrimas
- Dell Children's Medical Center of Central Texas, Austin
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Renkami dalyviai1 fazė
- Texas Oncology - Central South, Austin
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Renkami dalyviai1 fazė
- Texas Oncology - Central/South Texas /ID# 268563, Austin
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Renkami dalyviai2 fazė
- Texas Oncology - Central/South Texas /ID# 275154, Austin
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Renkami dalyviai2/3 fazė
- Texas Oncology - South Austin /ID# 276033, Austin
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Renkami dalyviai2 fazė
- Texas Oncology - Austin Central, Austin
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
Renkami dalyviai1 fazė
- GSK Investigational Site, Austin
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Renkami dalyviai1 fazė
- NEXT Oncology Austin, Austin
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
Renkami dalyviai1/2 fazė
- NEXT Oncology, Austin
Beat Childhood Cancer Specimen Banking and Data Registry
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
- Dell Children's Blood and Cancer Center, Austin
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Renkami dalyviai1/2 fazė
- NEXT Austin, Austin
A Study in Patients With Advanced Cancers
Renkami dalyviai1/2 fazė
- NEXT Oncology Austin, Austin
Vėžys (visų tipų) tyrimai kituose miestuose
- Houston, TX121 tyrimas
- New York City, NY110 tyrimai
- Boston, MA86 tyrimai
- Los Angeles, CA73 tyrimai
- Nashville, TN65 tyrimai
- Philadelphia, PA59 tyrimai
- Durham, NC58 tyrimai
- Washington, DC58 tyrimai
- Chicago, IL51 tyrimas
- Seattle, WA49 tyrimai
- Atlanta, GA49 tyrimai
- Arlington, VA48 tyrimai
Kiti tyrimai Austin
- Nedidelinių ląstelių plaučių vėžys30 tyrimai
- Nutukimas20 tyrimai
- Metastatinis vėžys19 tyrimai
- Storosios ir tiesiosios žarnos vėžys19 tyrimai
- Širdies nepakankamumas18 tyrimai
- Krūties vėžys18 tyrimai
- Antsvoris18 tyrimai
- Kiaušidžių vėžys17 tyrimai
- Endometrio vėžys15 tyrimai
- Prostatos vėžys15 tyrimai
- Depresija14 tyrimai
- Trigubai neigiamas krūties vėžys13 tyrimai
Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.